Comparison of 5-FU versus capecitabine in combination with mitomycin or cisplatin in the treatment of anal cancer

被引：3
|
作者：
Yu, Irene S.
Cheung, Winson Y.
机构：
[1] British Columbia Canc Agcy, Vancouver, BC, Canada
[2] BC Canc Agcy, Dept Med Oncol, Vancouver, BC, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.680
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
680
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer
    Taïeb, J
    Artru, P
    Baujat, B
    Mabro, M
    Carola, E
    Maindrault, F
    Tournigand, C
    Krulik, M
    Louvet, C
    de Gramont, A
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 (05) : 661 - 666
  • [22] Cost analysis of capecitabine versus 5-FU/LV for colorectal cancer patients in the Netherlands
    Postma, MJ
    van Hartskamp, D
    Jansman, FG
    Willemse, PH
    Brouwers, JR
    [J]. VALUE IN HEALTH, 2002, 5 (06) : 540 - 540
  • [23] Intergroup RTOG 9811 phase III comparison of chemoradiation with 5-FU and mitomycin vs 5-FU and cisplatin for anal canal carcinoma: Impact on disease-free, overall and colostomy-free survival
    Gunderson, L. L.
    Winter, K. A.
    Ajani, J. A.
    Pedersen, J. E.
    Benson, A. B.
    Thomas, C. R.
    Mayer, R. J.
    Haddock, M. G.
    Willett, C. G.
    Rich, T. A.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S24 - S24
  • [24] RANDOMIZED COMPARISON OF 5-FU ALONE OR COMBINED WITH MITOMYCIN AND CYTARABINE (MFC) IN THE TREATMENT OF ADVANCED GASTRIC-CANCER
    COCCONI, G
    DELISI, V
    DIBLASIO, B
    [J]. CANCER TREATMENT REPORTS, 1982, 66 (06): : 1263 - 1266
  • [25] 5-FU VERSUS COMBINATION THERAPY WITH TUBERCIDIN, STREPTOZOTOCIN, AND 5-FU IN THE TREATMENT OF PANCREATIC CARCINOMAS - COG PROTOCOL-7230
    AWRICH, A
    FLETCHER, WS
    KLOTZ, JH
    MINTON, JP
    HILL, GJ
    AUST, JB
    GRAGE, TB
    MULTHAUF, PM
    [J]. JOURNAL OF SURGICAL ONCOLOGY, 1979, 12 (03) : 267 - 273
  • [26] Comparison of 5-FU and leucovorin to gemcitabine in the treatment of pancreatic cancer
    Klein, B
    Sadikov, E
    Mishaeli, M
    Levin, I
    Figer, A
    [J]. ONCOLOGY REPORTS, 2000, 7 (04) : 875 - 877
  • [27] CISPLATIN PLUS 5-FU FOR THE TREATMENT OF ADENOCARCINOMA OF THE COLON
    LOEHRER, PJ
    EINHORN, LH
    WILLIAMS, SD
    HUI, SL
    ESTES, NC
    PENNINGTON, K
    [J]. CANCER TREATMENT REPORTS, 1985, 69 (12): : 1359 - 1363
  • [28] Capecitabine Plus Irinotecan Versus 5-FU/Leucovorin Plus Irinotecan in the Treatment of Colorectal Cancer: A Meta-analysis
    Guo, Yuanbiao
    Shi, Min
    Shen, Xiaoheng
    Yang, Chen
    Yang, Liu
    Zhang, Jun
    [J]. CLINICAL COLORECTAL CANCER, 2014, 13 (02) : 110 - 118
  • [29] COST MINIMIZATION ANALYSIS OF ADVANCED GASTRIC CANCER TREATMENT WITH CAPECITABINE/CISPLATIN (XP) VS. 5-FU/CISPLATIN (FP) REGIMENS IN POLISH SETTING
    Kawalec, P.
    Szawlowski, A.
    Federowicz, I
    Szkultecka-Debek, M.
    Russel-Szymczyk, M.
    [J]. VALUE IN HEALTH, 2008, 11 (06) : A473 - A473
  • [30] Economic assessment of capecitabinexisplatin versus 5-FU/Cisplatin regimens in adjuvant treatment of advanced gastric cancer in Spain
    Darba, J.
    Restovic, G.
    De Arellano, Ramirez A.
    [J]. ANNALS OF ONCOLOGY, 2008, 19 : 50 - 50
12345